Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice

Current Drug Delivery

Volumn 11, Issue 5, 2014, Pages 652-664

  Bhowmik, Tanmoy ^a   Saha, Partha Pratim ^a   DasGupta, Anjan Kumar ^a   Gomes, Antony ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Apoptosis; Caspase; Ehrlich ascites carcinoma; Gold nanoparticle; Snake venom; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; CASPASE 3; CASPASE 9; CYCLIN D1; FLUOROURACIL; GOLD NANOPARTICLE; INTERLEUKIN 10; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SNAKE VENOM; SNAKE VENOM PROTEIN TOXIN NKCT1; UNCLASSIFIED DRUG; VASCULOTROPIN; GOLD; METAL NANOPARTICLE; NKCT1 PROTEIN, NAJA KAOUTHIA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHASE CONTRAST MICROSCOPE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; RAMAN SPECTROMETRY; RAT; SCANNING ELECTRON MICROSCOPY; SURVIVAL TIME; TUMOR VOLUME; UPREGULATION; X RAY DIFFRACTION; ANIMAL; CARCINOMA, EHRLICH TUMOR; CELL CYCLE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; HUMAN; MOUSE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, EHRLICH TUMOR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ELAPID VENOMS; GOLD; HUMANS; MALE; METAL NANOPARTICLES; MICE; NEOPLASMS, EXPERIMENTAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84911460826     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140515101130     Document Type: Article

References (49)

1. Garcia, M.; Jemal, A.; Ward, E. M.; Center, M. M.; Hao, Y.; Siegel, RL.; Thun, M. J. Global cancer facts & figures 2007. Atlanta, GA: Am. Cancer Soc., 2007, 1, 1-46.
2. De Jong, H. W.; Burger, C. M.; Verheijen, A. M.; Geertsma, E. R. Detection of presence of gold nanoparticles in organs by Transmission in Electron Microscopy. Materials, 2010, 3, 4681-4694.
3. Brannon-Peppas, L. Recent advances on the use of biodegradable micro particles and nanoparticles in controlled drug delivery. Int. J. Pharm., 1995, 116, 1-9.
4. Debnath, A.; Saha, A.; Gomes, A.; Biswas, S.; Chakraborty, P.; Giri, B. A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom. Toxicon, 2010, 56, 569-579.
5. Debnath, A.; Chatterjee, U.; Das, M.; Vedasiromoni, R. J.; Gomes, A. Venom of Indian monocellate cobra and Russell's viper show anticancer activity in experimental models. J. Ethnopharmacol., 2007, 111, 681-684.
6. Bhowmik, T.; Saha, P. P.; Dasgupta, A.; Gomes, A. Antileukemic potential of PEGylated Gold nanoparticle conjugated with protein toxin (NKCT1) isolated from Indian cobra (Naja kaouthia) venom. Cancer Nano, 2013, 4, 39-55.
7. Ozaslan, M.; Karagoz, D. I.; Kilic, H. I.; Guldur, E. M. Ehrlich ascites carcinoma. Afr. J. Biotechnol., 2011, 10, 2375-2378.
8. Jaganathan, K. S.; Mondhe, D.; Wani, A. Z.; Pal, C. H.; Mandal, M., Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. J. Biomed. Biotechnol., 2010, 2010, 989163.
9. Hewala, I. T.; Ebied, A. S.; Abd El-Moneim, A. N.; Ramadan S. H.; El-Fekya, E. S. A study on the radioprotective effect of green tea extract in gamma-irridited Ehrlich carcinoma-bearing mice. JMRI, 2009, 30, 98-104.
10. Ahmed, H.; Chatterjee, P. B.; Debnath, K. A. Interaction and in vivo growth of Ehrlich ascites tumor cells by jacalin. J. Biosci., 1988, 13, 419-424.
11. Kisailus, D.; Najarian, M.; Weaver, C. J.; Morse, E. D. Functional-ized gold nanoparticles mimic catalytic activity of a polysiloxane-synthesizing enzyme. Adv. Mater, 2005, 17, 1234-1239.
12. Dolati, A.; Imanich, I.; Salehi, F.; Farahani, M. The effect of cysteine on electrodeposition of gold nanoparticles. Mater Sci. Eng., 2011, 176, 1307-1312.
13. Sobeczak-kupiec, A.; Malina, D.; Zimowska, M.; Wzorek, Z., Characterization of gold nanoparticles for various medical applications. Dig. J. Nanometer Bios., 2011, 6, 803-808.
14. Ankamwar, B. Biosynthesis of gold nanoparticles (Green-Gold) using leaf extract of Terminalia Catappa. E-J Chem., 2010, 7, 1334-1339.
15. Singh, P.; Kumari, K.; Katyal, A.; Katra, R.; Chandra, R. Synthesis and characterization of silver and gold nanoparticles in ionic liquid. Spectrochimica. Acta Part A, 2009, 73, 218-220.
16. Hu, J.; Wang, Z.; Li, J. Gold nanoparticles with special shapes: Controlled synthesis, surfaced-enhanced raman scattering, and the application in biodetection. Sensors, 2007, 7, 3299-3311.
17. 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Bioconjug. Chem., 2011, 22(5), 913-922.
18. Olmedo, I.; Araya, E.; Sanz, F.; Medina, E.; Arbiol, J.; Toledo, P.; Alvarez-Lueje, A.; Giralt, E.; Kogan, M. J. How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils. Bioconjug. Chem., 2008, 19(6), 1154-1163.
19. El-Missiry, A. M.; Othman, I. A.; Amer, A. M.; Mohamed, E. Otte-lione a inhibited proliferation of ehrlich ascites carcinoma cells in mice. Chem. Biol. Interact., 2012, 200, 119-127.
20. Hassan, I. A.; Abdel-Gawad I. E. Effect of Zizyphus leaves extract on mice suffering from ehrlich ascites carcinoma. Nat. Sci., 2010, 8, 234-244.
21. El-Missiry, A. M.; Abd El-Aziz, F. A. Influence of melatonin on proliferation and antioxidant system in ehrlich ascites carcinoma cells. Cancer Lett., 2000, 151, 119-125.
22. Das, T.; Bhattacharya, S.; Halder, B.; Biswas, A.; Dasgupta, S.; Gomes, A.; Gomes, A. Cytotoxic and antioxidant property of a purified fraction (NN-32) of Indian Naja naja venom on ehrlich ascites carcinoma in BALB/C mice. Toxicon, 2011, 57, 1065-1072.
23. Musta, A.; Konsgen, D.; Braicu, I. E.; Pirvulescu, C.; Sun, P.; Sofroni, D.; Lichtenegger, W.; Sehouli, J. Expression of IL-10 in patients with ovarian carcinoma. Anticancer Res., 2006, 26, 1715-1718.
24. Holm, M.; Thomsen, M.; Hoyer, M.; Hokland, P. Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and In Vitro BrdU incorporation into normal and malignant hematopoietic cells. Cytometry, 1998, 32, 28-36.
25. Bhattacharyya, A.; Choudhuri, T.; Pal, S.; Chattopadhyay, S.; Datta, K. G.; Sa, G.; Das, T. Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell. Carcinogenesis, 2003, 24, 75-80.
26. Fulda, S.; Debatin, K. M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 2006, 25, 4798-4811.
27. Sundaram, M.; Patra, S.; Maniasrasu, G. Antitumor activity of ethanol extracts of Gracilaria edulis (Gmelin) silva on Ehrlich ascites carcinoma-bearing mice. JCIM, 2012, 10, 430-435.
28. Lawal, A. R.; Ozaslan, D. M.; Odesanmi, S. O.; Karagoz, D. I.; Kilic, H. I.; Ebuehi, T. A. O. Cytotoxic and antiproliferative activity of Se-curidaca longependunculata aqueous extract on Ehrlich ascites carcinoma cells in swiss albino mice. IJARNP, 2012, 5, 19-27.
29. Choudhury, M. S.; Gupta, M.; Majumdar, K. U. Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing swiss albino mice. Oxid. Med. Cell Longev., 2010, 1, 61-70.
30. Chandru, H.; Sharada, C. A.; Bettadaiah, K. B.; Ananda K. C. S.; Rangappa, S. K., Jayashree, K. In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcu-min analogs on mouse Ehrlich ascites tumor. Bioorg. Med. Chem., 2007, 15, 7696-7703.
31. Nagatsu, M.; Richart, M. R.; Lambert, A. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma. Cancer Res., 1972, 32, 1966-1970.
32. Lazebnik, A. Y.; Medvedeva, D. N.; Zenin, V. V. Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells. Exp Cell Res., 1991, 195, 247-254.
33. Mondal, N.; Halder, K. K.; Kamila, M. M.; Debnath, C. M.; Pal, K. T.; Ghosal, K. S.; Sarkar, B. R.; Ganguly, S. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich ascites tumor bearing mice. Int. J. Pharm., 2010, 397, 194-200.
34. Jameela, R. S.; Latha, G. P.; Subramoniam, A.; Jayakrishnan, A. Antitumor activity of mitoxantrone-loaded chitosan microspheres against ehrlich ascites carcinoma. J. Pharm. Pharmacol., 1996, 48, 685-688.
35. Badr El-Din, N.; Noaman, E.; Ghoneum, M. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on ehrlich carcinoma-bearing mice. Nutr. Cancer, 2008, 60, 235-244.
36. Jantova, S.; Letasiova, S.; Brezova, V.; Cipak, L.; Labaj, J. Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J. Photochem. Pho-tobiol., 2006, 85, 163-176.
37. Sheela, L. M.; Ramakrishna, K. M.; Salimath, P. B. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells in inhibited by Glycyrrhiza glabra. Int. J. Immunopharmacol., 2006, 6, 494-498.
38. Konan, Y. N.; Gurney, R.; Allemann, E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm., 2002, 233, 239-252.
39. Moulari, B.; Beduneau, A.; Yann, P.; Alf, L. Nanoparticle targeting to Inflamed Tissues of the gastrointestinal tract. Curr. Drug Del., 2012, 10, 9-17.
40. Fastaia, J.; Dumont A. Pathogenesis of ascites in mice with peritoneal carcinomatosis. J. Nat. Cancer Inst., 1976, 56, 547-549.
41. Boehm, T.; Folkman, J.; Browder, T.; O'Reilly, M. S. Antiangio-genic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390, 404-407.
42. DeCosse, J. J.; Cennerazzo, W. J. Quality of life management of patients with colorectal cancer. CA Cancer J. Clin., 1997, 47, 198-206.
43. Mocellin, S.; Marincola, M. F.; Young, A. H. Interleukin-10 and the immune response against cancer: a counterpoint. J. leuko. Biol., 2005, 78, 1043-1051.
44. Baserga, R. Uptake of radioactive thymidine and cytidine by Ehr-lich ascites tumor cells in different stages of growth. Z. zellforsch, 1964, 64, 1-12.
45. Kouraklis, G.; Theocharis, S.; Vamvakas, P. Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World J. Surg. Oncol., 2006, 4, 5-17.
46. Rubbi, C. P.; Milner, J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J, 2003, 22, 6068-6077.
47. Rubbi, C. P.; Milner, J. P53-guardian of genome's guardian? Cell Cycle, 2003, 2, 20-21.
48. Lee, R. H.; Song, J. M.; Park, Y. M.; Kang, S. K.; Kim, Y. K.; Jung, J. S. Cisplastin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem. Pharmacol., 2001, 62, 1013-1023.
49. Acharya, S.; Sahoo, K. S. Sustained targeting of Bcr-Abl+ leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication of leukemia therapy. Biomaterials, 2011, 32, 5643-5662.